The Journal of the Pharmaceutical Management Science Association is the official research publication of the Pharmaceutical Management Science Association. Its purpose is to promote and embody the mission of the Pharmaceutical Management Science Association. In particular, the journal aims to help meet the following goals of the Association:

The key points in achieving this mission are:

• Raise awareness and promote use of Management Science in the pharmaceutical industry
• Foster sharing of ideas, challenges, and learning to increase overall level of knowledge and skill in this area
• Provide training opportunities to ensure continual growth within Pharmaceutical Management Science
• Encourage interaction and networking among peers in this area

The Journal is published in electronic format on the Association’s Web site. The Journal publishes manuscripts that advance knowledge across a wide range of practical issues in the application of techniques to solve Pharmaceutical Management Science problems, and that support the professional growth of Association members. Once per year, The Journal of the PMSA publishes a wide range of peer-reviewed practice papers, research articles and professional briefings written by industry experts and academics. Articles focus on the issues of key importance to pharmaceutical management science practitioners.

Please submit correspondence to:
Pharmaceutical Management Science Association
1024 Capital Center Drive, Suite 205
Frankfort, KY 40601
This email address is being protected from spambots. You need JavaScript enabled to view it.
(877) 279-3422

PLEASE NOTE:

Abstracts for the 2024 edition of the Journal are now being accepted. Click here to read our submission guidelines. — Abstracts are due by September 5, 2023.

Summary of manuscript structure:
An abstract should be included, comprising approximately 150 words. Six key words are also required. All articles and papers should be accompanied by a short (about 100 words) description of the author(s) and, if appropriate, the organization of which he or she is a member.

Industry submissions:
For practitioners working in the pharmaceutical industry, and the consultants and other supporting professionals working with them, the Journal offers the opportunity to publish leading-edge thinking to a targeted and relevant audience.

Industry submissions should represent the work of the practical application of management science methods or techniques to solving a specific pharmaceutical marketing analytic problem. Preference will be given to papers presenting original data (qualitative or quantitative), case studies and examples. Submissions that are overtly promotional are discouraged and will not be accepted.

Industry submissions should aim for a length of 3000-5000 words and should be written in a 3rd person, objective style. They should be referenced to reflect the prior work on which the paper is based. References should be presented in Vancouver format.

Academic submissions:
For academics studying the domains of management science in the pharmaceutical industry, the journal offers an opportunity for early publication of research that is unlikely to conflict with later publication in higher-rated academic journals.

Academic submissions should represent original empirical research or critical reviews of prior work that are relevant to the pharmaceutical management science industry. Academic papers are expected to balance theoretical foundations and rigor with relevance to a non-academic readership. Submissions that are not original or that are not relevant to the industry are discouraged and will not be accepted.

Academic submissions should aim for a length of 3000-5000 words and should be written in a 3rd person, objective style. They should be referenced to reflect the prior work on which the paper is based. References should be presented in Vancouver format.

Expert Opinion Submissions:
For experts working in the Pharmaceutical Management Science area, the journal offers the opportunity to publish expert opinions to a relevant audience.

Expert opinion submissions should represent original thinking in the areas of marketing and strategic management as it relates to the pharmaceutical industry. Expert opinions could constitute a review of different methods or data sources, or a discussion of relevant advances in the industry.

Expert opinion submissions should aim for a length of 2000-3000 words and should be written in a 3rd person, objective style. Whilst references are not essential for expert opinion submissions, they are encouraged and should be presented in Vancouver format.

Industry, academic and expert opinion authors are invited to contact the editor directly if they wish to clarify the relevance of their submission to the journal or seek guidance regarding content before submission. In addition, academic or industry authors who wish to cooperate with other authors are welcome to contact the editor who may be able to facilitate useful introductions.

Items to consider:

1. What is the central message of the article you propose to write (the 'aha')? What is important, useful, new, or counter-intuitive about your idea? Why do managers need to know about it?
2. How can your idea be applied in business today (the 'so what')?
3. For which kinds of companies would the idea NOT work well? For which kinds of companies would it work especially well? Why?
4. What projects/research have you conducted to support the argument in your article?
5. On what previous work (either of your own or of others) does this idea build?
6. What is the source of your authority? What academic, professional, or personal experience will you draw on?